Reactivation of Hepatitis B Virus Among Patients With Cancer Receiving Immunotherapy

Reactivation of Hepatitis B Virus Among Patients With Cancer Receiving Immunotherapy

Bibliographic Details
Main Authors:	Jessica P. Hwang, Bulent Yilmaz
Format:	Article
Language:	English
Published:	Innovative Healthcare Institute 2021-05-01
Series:	Journal of Immunotherapy and Precision Oncology
Subjects:	hepatitis b virus immunotherapy immune checkpoint inhibitors reactivation
Online Access:	https://jipo.org/doi/pdf/10.36401/JIPO-20-19

Similar Items

Hepatitis B reactivation in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
by: Zhengzheng Xia, et al.
Published: (2023-09-01)

The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening Rate
by: Laia Aceituno, et al.
Published: (2022-07-01)

Hepatitis B Virus Reactivation with Immunosuppression: A Hidden Threat?
by: Sama Anvari, et al.
Published: (2024-01-01)

Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment
by: Po-Hsin Lee, et al.
Published: (2022-12-01)

Immune-Escape Hepatitis B Virus Mutations Associated with Viral Reactivation upon Immunosuppression
by: Ivana Lazarevic, et al.
Published: (2019-08-01)

Feasibility of immunotherapy in cancer patients with persistent or past hepatitis B or C virus infection
by: Tasuku Nakabori, et al.
Published: (2022-05-01)

Dendritic cell‐based immunotherapy: A potential therapeutic option for chronic Hepatitis B virus infection
by: Xuejie Wu, et al.
Published: (2023-02-01)

Pegfilgrastim-Induced Aortitis in a Patient with Small-Cell Lung Cancer Who Received Immunotherapy Combined with Chemotherapy
by: Takanori Ito, et al.
Published: (2023-11-01)

Hepatic Failure by Spontaneous Reactivation of Hepatitis B Virus without a Trigger Factor in a Patient with Anti-HBs
by: Doh Hyung Kim, et al.
Published: (2018-06-01)

Hepatitis B virus reactivation in seronegative occult hepatitis B patient receiving ibrutinib therapy
by: Lok-Ka Lam, et al.
Published: (2023-08-01)

Immune Checkpoint Inhibitors in Patients With Cancer and Infection by Hepatitis B or C Virus: A Perspective Through the Results of a European Survey
by: Marco Tagliamento, MD, et al.
Published: (2023-01-01)

Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection Exhibited Favorable Survival from Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
by: Qi Du, et al.
Published: (2023-10-01)

Newcastle Disease Virus at the Forefront of Cancer Immunotherapy
by: Bharat Burman, et al.
Published: (2020-11-01)

A case report of hepatitis B virus reactivation 19 months after cessation of chemotherapy with rituximab
by: Xiangjuan Guo, et al.
Published: (2022-12-01)

The Role of CTLA-4 in T Cell Exhaustion in Chronic Hepatitis B Virus Infection
by: Ása Didriksen Apol, et al.
Published: (2023-05-01)

Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors
by: Chang-Myung Oh, et al.
Published: (2020-10-01)

Clinical outcomes of patients with acute lymphoblastic leukemia receiving the hyper-CVAD regimen and assessment of the risk of hepatitis flares due to hepatitis B virus reactivation after chemotherapy
by: Man Fai Law, et al.
Published: (2021-03-01)

Oncolytic Viruses and Immune Checkpoint Inhibitors: The “Hot” New Power Couple
by: Charlotte Lovatt, et al.
Published: (2023-08-01)

Direct-Acting Antivirals and the Risk of Hepatitis B Reactivation in Hepatitis B and C Co-Infected Patients: A Systematic Review and Meta-Analysis
by: Joo Hyun Oh, et al.
Published: (2022-11-01)

Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy
by: Hong-My Nguyen, et al.
Published: (2020-02-01)

Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B
by: Zhiyong Ma, et al.
Published: (2018-01-01)

Harnessing viral power: immunotherapy's synergy with targeted oncolytic viruses
by: Mohammad Shenagari, et al.
Published: (2023-12-01)

Hepatitis C Virus and Hepatitis B Virus Co-Infection
by: Yi-Fen Shih, et al.
Published: (2020-07-01)

Reactivation of Hepatitis B Virus in Patients with Multiple Myeloma
by: Yutaka Tsukune, et al.
Published: (2019-11-01)

New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3
by: Ioannis-Alexios Koumprentziotis, et al.
Published: (2024-01-01)

RFX1 participates in doxorubicin‐induced hepatitis B virus reactivation
by: Jie Wang, et al.
Published: (2018-05-01)

A Very Young Adult Female Patient with Hepatitis B Flare: A Case Report
by: Andreas Agung Kurniawan, et al.
Published: (2023-07-01)

Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection
by: Ana Maria Ortega-Prieto, et al.
Published: (2017-09-01)

Hepatitis B Virus-Associated Hepatocellular Carcinoma
by: Giacomo Emanuele Maria Rizzo, et al.
Published: (2022-05-01)

Modified Alphavirus-Vesiculovirus Hybrid Vaccine Vectors for Homologous Prime-Boost Immunotherapy of Chronic Hepatitis B
by: Carolina Chiale, et al.
Published: (2020-06-01)

Recent Advances and Challenges in Uveal Melanoma Immunotherapy
by: Yihang Fu, et al.
Published: (2022-06-01)

The Management Problems of Patient with Chronic Hepatitis B Infection and Its Reactivation
by: Tri Asih Imro'ati, et al.
Published: (2020-07-01)

Short review of immunotherapy toxicity
by: Ivana Canjko, et al.
Published: (2021-01-01)

Current Trends in Cancer Immunotherapy
by: Ivan Y. Filin, et al.
Published: (2020-12-01)

Survival outcomes of patients with head and neck squamous cell cancer with hepatitis B virus infection: An analysis from an endemic tertiary center
by: Cheng‐Lun Lai, et al.
Published: (2023-03-01)

The Role of Immunotherapy in the Treatment of Adrenocortical Carcinoma
by: Izabela Karwacka, et al.
Published: (2021-01-01)

CD4<sup>+</sup> T Cells in Chronic Hepatitis B and T Cell-Directed Immunotherapy
by: Sonja I. Buschow, et al.
Published: (2021-05-01)

Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting
by: James H. A. Clubb, et al.
Published: (2023-02-01)

Clinical Efficacy and Future Prospects of Immunotherapy in Lung Cancer
by: Tomonari Kinoshita, et al.
Published: (2021-09-01)

Screening of hepatitis B and C viral infection, recognition of risk factors, and immunization of patients against hepatitis B virus: a module developed for effective hepatitis control
by: Samina Ejaz, et al.
Published: (2023-11-01)